214450.KQ PharmaResearch Co., Ltd. Loading... : Bullish and Bearish Analyst Opinions
Loading chart...
Top Calls
Feed
08:36
May 07
May 07
PharmaResearch building base for upside.
PharmaResearch is building a base and gradually rising from its bottom, indicating a potential reversal despite weak overall market.
MED
00:25
May 07
May 07
Cheap pharma/cosmetics stock, earnings catalyst
PharmaResearch (파마리서치) is very cheap and has an upcoming earnings release. The company is a leading player in the Korean cosmetics and dermatology field, and strong export data supports its growth.
MED
11:01
May 06
May 06
Pharmaresearch weak and avoid.
Pharmaresearch is weak and still below its 120-day moving average; the speaker advises to avoid it and keep distance as it may continue to underperform.
MED
07:00
May 06
May 06
Pharma/biotech to rally on rate cuts.
The Korean pharma/biotech sector is underperforming but presents a long-term opportunity. When the new Fed chair (Kevin Warsh) signals rate cuts, the sector could rally quickly. PharmaResearch specifically is expected to move higher.
MED
12:00
May 04
May 04
PharmaResearch cheap, good earnings
PharmaResearch has strong earnings (profit growth) and is trading at a low P/E (~15x) after a sharp correction. Concerns over market share loss and failed spin-off are overblown. If earnings stay solid, the stock can recover to the 400,000-500,000 won range.
MED
About 214450.KQ Analyst Coverage
Buzzberg tracks 214450.KQ (PharmaResearch Co., Ltd.) across 2 sources. 4 bullish vs 0 bearish calls from 1 analysts. Sentiment: predominantly bullish (80%). 5 total trade ideas tracked.